IslamicImaratsofAfghanistan
Ministryofpublichealth
ParwanHospital
Obstetricsandgynecologydepartment
Vulvar Cancer
Vaginal Cancer
By : Basira Mansoori
VulvarCancer
 Relevant Anatomy
 Epidemiology
 Risk factors
 Diagnosis
 Staging
 Prognosis
 Treatment
 Surveillance
 RECURRENT DISEASE
 VERRUCOUS CARCINOMA
 MELANOMA
 Metastatic Disease
 BASAL CELL CARCINOMA
 VULVAR SARCOMA
 VULVAR PAGET DISEASE
 Bartholin GLAND CARCINOMA
 VULVAR PAGET DISEASE
 CANCER METASTATIC TO The VULVA
Relevant
Anatomy
The vulva includes the mons pubis, labia major and
minor, clitoris, vestibule, vestibular bulbs, Bartholin
glands, lesser vestibular glands, Para urethral glands,
and the urethral and vaginal openings.
Relevant
Anatomy
Epidemiology
Of vulvar tumors, approximately 90 percent are
squamous cell carcinoma . Malignant melanoma is the
second most common, but rare histologic subtypes may
also be considered.
Riskfactors
Age is a prominent factor and positively correlates with
this cancer.
These cancers are usually described histologically as
basaloid or warty and are linked with human
papillomavirus (HPV).
Herpes simplex virus infection is also linked with vulvar
cancer in several studies .
Chronic immunosuppression can predispose to vulvar
cancer.
Lichen sclerosus is a chronic vulvar infammatory disease
and is related to vulvar cancer development.
Diagnosis
Symptoms:
Women with VIN and vulvar cancer commonly present
with pruritus and a visible lesion However, pain,
bleeding, ulceration, or inguinal mass may be other
complaints. Manifestations can persist for weeks or
months before diagnosis, as many patients may be
embarrassed or may not recognize the significance to
their symptoms.
Lesion
Evaluation
Lesions may be raised, ulcerated, pigmented, or warty,
but in younger women with multi focal disease, as well-
defined mass is not always present.
For this, colposcopic examination o the vulva, termed
vulvoscopy, can direct biopsy site selection.
StagingSystems
The International Federation of Gynecology and
Obstetrics (FIGO) advocates surgical staging of
patients with vulvar cancer that is based on a tumor,
nodal, metastatic ( TNM) calcinations. Thus, staging
involves: (1) primary tumor resection to obtain tumor
dimensions and (2) dissection o superficial and deep
inguinofemoral lymph nodes to evaluate tumor
spread .
vulva and vaginal cancers by Basira.pptx
PROGNOSIS
Overall survival rates of women with squamous cell
carcinoma of the vulva are relatively good.
Apart rom FIGO stage, other important prognostic
factors include lymph node metastasis, lesion size, depth
of invasion, resected-mar-gin status, and lymphatic
vascular space involvement (LVSI).
Of these, lymph node metastasis is the single most
important vulvar cancer predictor.
vulva and vaginal cancers by Basira.pptx
Treatment
Surgery :
For vulvar cancer treatment, surgery is often an integral
part .
Potential procedures, in increasing order of radicality,
include wide local excision (WLE), radical partial
vulvectomy, and rad-ical complete vulvectomy.
vulva and vaginal cancers by Basira.pptx
Inguinofemoral
Lymphadenecto
my
This procedure is usually an integral part o surgical
cancer staging and accompanies radical partial or radical
complete vulvectomy.
SentinelLymph
NodeBiopsy
As another less morbid option, selective dissection of a
solitary node or nodes, termed sentinel lymph node
biopsy (SLNB).
Physiologically, the first lymph node to receive tumor
lymphatic drainage is termed the sentinel lymph node .
vulva and vaginal cancers by Basira.pptx
SURVEILLANCE
After completing primary treatment, all patients receive
thorough physical examination, including inguinal lymph
node palpation and pelvic examination.
Vulvoscopy and biopsies are performed if concerning
areas are noted during history or physical examination.
Radiologic imaging and biopsies to diagnose possible
tumor recurrence are performed as indicated.
RECURRENT
DISEASE
Vulvar Recurrences
Distant Recurrences
VERRUCOUS
CARCINOMA
This rare variant of squamous cell carcinoma constitutes
less than 1 percent of all vulvar cancers.
MELANOMA
Melanoma is the second most common vulvar cancer and
accounts or 10 percent of all vulvar malignancies .
BASALCELL
CARCINOMA
Basal cell carcinoma (BCC) of the vulva accounts or <2
percent of all vulvar cancers and is most commonly
found in elderly women.
VULVAR
SARCOMA
Sarcoma of the vulva is rare, and leiomyosarcoma,
malignant fibrous histiocytoma, epithelioid sarcoma, and
malignant rhabdoid tumor are the more requently
encountered histologic types .
Of these, leiomyosarcoma appears to be most common .
VULVARPAGET
DISEASE
Extramammary Paget disease is a heterogeneous group
of intraepithelial neoplasias and when present on the
vulva, appears as an eczematoid, red, weeping area.
CANCER
METASTATICTO
ThEVULVA
Metastatic tumors make up approximately 8 percent of
all vulvar cancers .
Tumors may extend from primary cancers of the
bladder, urethra, vagina, or rectum. Less proximate
cancers include those from the breast, kidney, lung,
stomach, and gestational choriocarcinoma.
VaginalCancer
Relevant Anatomy
Incidence
Squamous cell carcinoma
Adenocarcinoma
Mesynchymal Tumors
Melanoma
Relevant
Anatomy
During embryogenesis, the müllerian ducts fuse caudally
to form the uterovaginal canal The canal’s distal portion
forms the proximal vagina, whereas the distal vagina
arises from the urogenital sinus.
vulva and vaginal cancers by Basira.pptx
Incidence
Vaginal cancer rates increase with age and peak among
women ≥
80 years. The median age at diagnosis is 58
.
Of histologic forms, squamous cell carcinoma accounts
for 70 to 80 percent of all primary vaginal cancer cases.
SQUAMOUS
CELL
CARCINOMA1
Risks
Diagnosis
Staging
Prognosis
Treatment
ADENOCARCIN
OMA
Primary adenocarcinoma of the vagina is rare, making
up only 13 percent of all vaginal cancers. Histologic
types include clear cell, endometrioid, mucinous, and
serous carcinoma, and these may arise in endometriosis
foci, in areas of vaginal adenosis, in periurethral glands,
or in wolfan duct rem-nants.
ClearCell
Adenocarcinom
a
Of primary vaginal adenocarcinomas, the clear cell type
is most closely associated with DES exposure.
MESENChYMAL
TUMORS
Embryonal Rabdomyosarcoma:
This is the most common malignancy of the vagina in
infants and children, and most embryonal
rhabdomyosarcomas are the sarcoma botryoides
subtype .
Leiomyosarcom
a
This is the most common type of vaginal sarcoma in
adults. However, it makes up no more than 1 percent of
vaginal malignancies, and only 140 cases have been
described in the literature to date.
vulva and vaginal cancers by Basira.pptx
MELANOMA
Primary malignant melanoma in the vagina is rare,
accounting for less than 3 percent of all vaginal cancers.
In women, only 1.6 percent o melanomas are genital
vulva and vaginal cancers by Basira.pptx
Thanks

More Related Content

PPTX
Presentation on International Patient Safety Goals (JCI)
PPTX
BLOOD TRANSFUSION REACTIONS.
PPTX
What is role of pathologist
PPTX
Nursing opportunities in aiims and central .govt sector
PPT
Surgical safety
PPT
Clinical Pathways
PDF
Types of Fluids
PPT
Organ Transplantation
Presentation on International Patient Safety Goals (JCI)
BLOOD TRANSFUSION REACTIONS.
What is role of pathologist
Nursing opportunities in aiims and central .govt sector
Surgical safety
Clinical Pathways
Types of Fluids
Organ Transplantation

What's hot (18)

DOCX
Ambulatory care
PPT
Evolution of healthcare_delivery
PPTX
The use of guidelines and clinical pathways
PPT
Acute leukemias 2-csbrp
PPTX
pp theorist
PPTX
Communication using the sbar tool
PPTX
ACUTE MYELOID LEUKAEMIA.pptx
PPTX
DOC
Quiz in cancer
PPTX
ppt on patient satisfaction
PPTX
Human Digestive Anatomy
PPTX
CLINICAL PATHWAY and CLINICAL PRACTICE GUIDELINES
PPT
Evidence-Based Practice and the Future of Nursing
PPTX
Biology form 5 process of oogenesis
PPTX
Clinical pathways
PPT
Platelet transfusion
PDF
How to improve patient flow in emergency and ambulatory care, pop up uni, 10a...
PPTX
Fnac breast
Ambulatory care
Evolution of healthcare_delivery
The use of guidelines and clinical pathways
Acute leukemias 2-csbrp
pp theorist
Communication using the sbar tool
ACUTE MYELOID LEUKAEMIA.pptx
Quiz in cancer
ppt on patient satisfaction
Human Digestive Anatomy
CLINICAL PATHWAY and CLINICAL PRACTICE GUIDELINES
Evidence-Based Practice and the Future of Nursing
Biology form 5 process of oogenesis
Clinical pathways
Platelet transfusion
How to improve patient flow in emergency and ambulatory care, pop up uni, 10a...
Fnac breast
Ad

Similar to vulva and vaginal cancers by Basira.pptx (20)

PPT
carcinoma vulva
PDF
4 u1.0-b978-1-4160-6643-9..00193-4..docpdf
PPTX
Carcinoma vagina dr.kiran
PPTX
Vulval Cancer Diagnosis and Staging
DOC
Vulval cancer
PPTX
vaginal cancer 2022 .pptx
PPTX
E uterus
PPTX
Presentation1.pptx, radiological imaging of uterine cervix diseases.
PPTX
GROUP 13.pptxppppppppppppppppppiuiiuuuuuuuuuuuu
PPTX
gynaecology.Carcinoma of the endometrium.(dr.rojan)
PPT
Uterine cancer
PPT
Kanser dan wanita
PDF
OVARIAN CNCER powerpoint presentation....
PDF
Malignant ovarian tumour review in details.pdf
PPTX
Ovarian cancer
PPT
Carcinoma vagina
PPTX
UTERINE AND CERVIX CANCER.pptx
PPTX
document.pptx
DOCX
PREMALIGNANT AND MALIGNANT LESIONS OF THE VAGINA.docx
PPT
CARCINOMA URINARY BLADDER
carcinoma vulva
4 u1.0-b978-1-4160-6643-9..00193-4..docpdf
Carcinoma vagina dr.kiran
Vulval Cancer Diagnosis and Staging
Vulval cancer
vaginal cancer 2022 .pptx
E uterus
Presentation1.pptx, radiological imaging of uterine cervix diseases.
GROUP 13.pptxppppppppppppppppppiuiiuuuuuuuuuuuu
gynaecology.Carcinoma of the endometrium.(dr.rojan)
Uterine cancer
Kanser dan wanita
OVARIAN CNCER powerpoint presentation....
Malignant ovarian tumour review in details.pdf
Ovarian cancer
Carcinoma vagina
UTERINE AND CERVIX CANCER.pptx
document.pptx
PREMALIGNANT AND MALIGNANT LESIONS OF THE VAGINA.docx
CARCINOMA URINARY BLADDER
Ad

More from Azadov1 (14)

PPTX
Atelectasis_Presentation by dr azadov.pptx
PPTX
Bartholin_Gland_Duct_Marsupialization.pptx
PPTX
Nephrotic_Syndrome_Seminar by drazadov.pptx
PPTX
Potassium_Disorders_Harrison by Dr Azad.pptx
PPTX
Lung_Abscess_Presentation full details.pptx
PPTX
Potassium imbalances final by azad .pptx
PPTX
Bartholin_Gland_Duct_Marsupialization.pptx
PPT
Respiratory Failure typse and treatment by azad.ppt
PPTX
Management of Trauma in pregnant patients.pptx
PPTX
Community Aquired Pneumonia by Dr mozammel.pptx
PPTX
Gouty Arthritis updates by arman 420.pptx
PPTX
ventilator Presentation1 full file .pptx
PPTX
انواع زرقیات _ زرقیات او ډولونه يې.pptx
PPTX
Diabetesinsipidus by Dr Azad 2024 jan.pptx
Atelectasis_Presentation by dr azadov.pptx
Bartholin_Gland_Duct_Marsupialization.pptx
Nephrotic_Syndrome_Seminar by drazadov.pptx
Potassium_Disorders_Harrison by Dr Azad.pptx
Lung_Abscess_Presentation full details.pptx
Potassium imbalances final by azad .pptx
Bartholin_Gland_Duct_Marsupialization.pptx
Respiratory Failure typse and treatment by azad.ppt
Management of Trauma in pregnant patients.pptx
Community Aquired Pneumonia by Dr mozammel.pptx
Gouty Arthritis updates by arman 420.pptx
ventilator Presentation1 full file .pptx
انواع زرقیات _ زرقیات او ډولونه يې.pptx
Diabetesinsipidus by Dr Azad 2024 jan.pptx

Recently uploaded (20)

PPTX
Approch to weakness &paralysis pateint.pptx
PPTX
Bronchial Asthma2025 GINA Guideline.pptx
DOCX
ORGAN SYSTEM DISORDERS Zoology Class Ass
PPTX
presentation on causes and treatment of glomerular disorders
PDF
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
PPT
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
PDF
Diabetes mellitus - AMBOSS.pdf
PDF
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
PPTX
presentation on dengue and its management
PPT
fiscal planning in nursing and administration
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
PPTX
critical care nursing 12.pptxhhhhhhhhjhh
PPTX
Peripheral Arterial Diseases PAD-WPS Office.pptx
PPTX
Communicating with the FDA During an Inspection -August 26, 2025 - GMP.pptx
PPSX
Man & Medicine power point presentation for the first year MBBS students
PPTX
Nutrition needs in a Surgical Patient.pptx
PDF
Integrating Traditional Medicine with Modern Engineering Solutions (www.kiu....
PPTX
Computed Tomography: Hardware and Instrumentation
PPTX
Indications for Surgical Delivery...pptx
PPTX
Surgical anatomy, physiology and procedures of esophagus.pptx
Approch to weakness &paralysis pateint.pptx
Bronchial Asthma2025 GINA Guideline.pptx
ORGAN SYSTEM DISORDERS Zoology Class Ass
presentation on causes and treatment of glomerular disorders
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
Diabetes mellitus - AMBOSS.pdf
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
presentation on dengue and its management
fiscal planning in nursing and administration
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
critical care nursing 12.pptxhhhhhhhhjhh
Peripheral Arterial Diseases PAD-WPS Office.pptx
Communicating with the FDA During an Inspection -August 26, 2025 - GMP.pptx
Man & Medicine power point presentation for the first year MBBS students
Nutrition needs in a Surgical Patient.pptx
Integrating Traditional Medicine with Modern Engineering Solutions (www.kiu....
Computed Tomography: Hardware and Instrumentation
Indications for Surgical Delivery...pptx
Surgical anatomy, physiology and procedures of esophagus.pptx

vulva and vaginal cancers by Basira.pptx

  • 2. VulvarCancer  Relevant Anatomy  Epidemiology  Risk factors  Diagnosis  Staging  Prognosis  Treatment  Surveillance  RECURRENT DISEASE  VERRUCOUS CARCINOMA  MELANOMA  Metastatic Disease  BASAL CELL CARCINOMA  VULVAR SARCOMA  VULVAR PAGET DISEASE  Bartholin GLAND CARCINOMA  VULVAR PAGET DISEASE  CANCER METASTATIC TO The VULVA
  • 3. Relevant Anatomy The vulva includes the mons pubis, labia major and minor, clitoris, vestibule, vestibular bulbs, Bartholin glands, lesser vestibular glands, Para urethral glands, and the urethral and vaginal openings.
  • 5. Epidemiology Of vulvar tumors, approximately 90 percent are squamous cell carcinoma . Malignant melanoma is the second most common, but rare histologic subtypes may also be considered.
  • 6. Riskfactors Age is a prominent factor and positively correlates with this cancer. These cancers are usually described histologically as basaloid or warty and are linked with human papillomavirus (HPV). Herpes simplex virus infection is also linked with vulvar cancer in several studies . Chronic immunosuppression can predispose to vulvar cancer. Lichen sclerosus is a chronic vulvar infammatory disease and is related to vulvar cancer development.
  • 7. Diagnosis Symptoms: Women with VIN and vulvar cancer commonly present with pruritus and a visible lesion However, pain, bleeding, ulceration, or inguinal mass may be other complaints. Manifestations can persist for weeks or months before diagnosis, as many patients may be embarrassed or may not recognize the significance to their symptoms.
  • 8. Lesion Evaluation Lesions may be raised, ulcerated, pigmented, or warty, but in younger women with multi focal disease, as well- defined mass is not always present. For this, colposcopic examination o the vulva, termed vulvoscopy, can direct biopsy site selection.
  • 9. StagingSystems The International Federation of Gynecology and Obstetrics (FIGO) advocates surgical staging of patients with vulvar cancer that is based on a tumor, nodal, metastatic ( TNM) calcinations. Thus, staging involves: (1) primary tumor resection to obtain tumor dimensions and (2) dissection o superficial and deep inguinofemoral lymph nodes to evaluate tumor spread .
  • 11. PROGNOSIS Overall survival rates of women with squamous cell carcinoma of the vulva are relatively good. Apart rom FIGO stage, other important prognostic factors include lymph node metastasis, lesion size, depth of invasion, resected-mar-gin status, and lymphatic vascular space involvement (LVSI). Of these, lymph node metastasis is the single most important vulvar cancer predictor.
  • 13. Treatment Surgery : For vulvar cancer treatment, surgery is often an integral part . Potential procedures, in increasing order of radicality, include wide local excision (WLE), radical partial vulvectomy, and rad-ical complete vulvectomy.
  • 15. Inguinofemoral Lymphadenecto my This procedure is usually an integral part o surgical cancer staging and accompanies radical partial or radical complete vulvectomy.
  • 16. SentinelLymph NodeBiopsy As another less morbid option, selective dissection of a solitary node or nodes, termed sentinel lymph node biopsy (SLNB). Physiologically, the first lymph node to receive tumor lymphatic drainage is termed the sentinel lymph node .
  • 18. SURVEILLANCE After completing primary treatment, all patients receive thorough physical examination, including inguinal lymph node palpation and pelvic examination. Vulvoscopy and biopsies are performed if concerning areas are noted during history or physical examination. Radiologic imaging and biopsies to diagnose possible tumor recurrence are performed as indicated.
  • 20. VERRUCOUS CARCINOMA This rare variant of squamous cell carcinoma constitutes less than 1 percent of all vulvar cancers.
  • 21. MELANOMA Melanoma is the second most common vulvar cancer and accounts or 10 percent of all vulvar malignancies .
  • 22. BASALCELL CARCINOMA Basal cell carcinoma (BCC) of the vulva accounts or <2 percent of all vulvar cancers and is most commonly found in elderly women.
  • 23. VULVAR SARCOMA Sarcoma of the vulva is rare, and leiomyosarcoma, malignant fibrous histiocytoma, epithelioid sarcoma, and malignant rhabdoid tumor are the more requently encountered histologic types . Of these, leiomyosarcoma appears to be most common .
  • 24. VULVARPAGET DISEASE Extramammary Paget disease is a heterogeneous group of intraepithelial neoplasias and when present on the vulva, appears as an eczematoid, red, weeping area.
  • 25. CANCER METASTATICTO ThEVULVA Metastatic tumors make up approximately 8 percent of all vulvar cancers . Tumors may extend from primary cancers of the bladder, urethra, vagina, or rectum. Less proximate cancers include those from the breast, kidney, lung, stomach, and gestational choriocarcinoma.
  • 26. VaginalCancer Relevant Anatomy Incidence Squamous cell carcinoma Adenocarcinoma Mesynchymal Tumors Melanoma
  • 27. Relevant Anatomy During embryogenesis, the müllerian ducts fuse caudally to form the uterovaginal canal The canal’s distal portion forms the proximal vagina, whereas the distal vagina arises from the urogenital sinus.
  • 29. Incidence Vaginal cancer rates increase with age and peak among women ≥ 80 years. The median age at diagnosis is 58 . Of histologic forms, squamous cell carcinoma accounts for 70 to 80 percent of all primary vaginal cancer cases.
  • 31. ADENOCARCIN OMA Primary adenocarcinoma of the vagina is rare, making up only 13 percent of all vaginal cancers. Histologic types include clear cell, endometrioid, mucinous, and serous carcinoma, and these may arise in endometriosis foci, in areas of vaginal adenosis, in periurethral glands, or in wolfan duct rem-nants.
  • 32. ClearCell Adenocarcinom a Of primary vaginal adenocarcinomas, the clear cell type is most closely associated with DES exposure.
  • 33. MESENChYMAL TUMORS Embryonal Rabdomyosarcoma: This is the most common malignancy of the vagina in infants and children, and most embryonal rhabdomyosarcomas are the sarcoma botryoides subtype .
  • 34. Leiomyosarcom a This is the most common type of vaginal sarcoma in adults. However, it makes up no more than 1 percent of vaginal malignancies, and only 140 cases have been described in the literature to date.
  • 36. MELANOMA Primary malignant melanoma in the vagina is rare, accounting for less than 3 percent of all vaginal cancers. In women, only 1.6 percent o melanomas are genital